Treatment of psoriasis with calcipotriol and other vitamin D analogues

Journal of the American Academy of Dermatology

Volumn 27, Issue 6, 1992, Pages 1001-1008

  Kragballe, Knud ^a  

^a NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; BETAMETHASONE VALERATE; CALCIPOTRIOL; CALCITRIOL; CALCIUM; COLECALCIFEROL DERIVATIVE; DITHRANOL; DNA; MESSENGER RNA; TACALCITOL; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN RECEPTOR;

BINDING AFFINITY; CALCIUM METABOLISM; CELL DIFFERENTIATION; CELL GROWTH; DNA SYNTHESIS; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; FIBROBLAST; HUMAN; IMMUNE SYSTEM; KERATINOCYTE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIASIS; RECEPTOR AFFINITY; REVIEW; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION; VITAMIN D METABOLISM;

ADMINISTRATION, TOPICAL; CALCITRIOL; DERMATOLOGIC AGENTS; HUMAN; PSORIASIS; VITAMIN D;

EID: 0026459274     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0190-9622(92)70302-V     Document Type: Article

References (61)

1. Vitamin D receptors: nature and function
2. 3 increases intracellular calcium in human keratinocytes
3. Receptor mediated rapid action of 1,25-dihydroxy cholecalciferol: increase of intracellular cyclic GMP in human skin fibroblasts
4. 3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid
5. 3 receptor in human skin biopsies
6. 3
7. Nuclear uptake of 1,25-dihydroxy chole-calciferol in dispersed fibroblasts cultured from normal human skin
8. 3 receptors in normal and psoriatic skin
9. 3
10. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions
11. 3 in human breast cancer cells
12. 3 enhances antiproliferative effect and transcription of TGF-beta 1 on human keratinocytes
13. 3on normal human keratinocytes cultured in serum-free medium
14. Agonist/inositol triphosphate-induced release of calcium from murine keratinocytes: a possible link with keratinocyte differentiation
15. 3 analogue (calci-potriol) on epidermal cells
16. 3 analogues: a strong effect on the prolongation of mouse skin allograft survival
17. 3 regulator of interleukin-8 expression and production
18. 3
19. 3 treatment in psoriasis vulgaris
20. Abnormal vitamin D metabolism in patients with psoriasis
21. A novel approach for the evaluation and treatment of psoriasis
22. Vitamin D metabolism in psoriasis before and after phototherapy
23. Inverse relationship between severity of psoriasis and serum 1, 25-dihydroxyvitamin D level
24. Psoriasis exacerbated by hypoparathyroidism with hypoxalcemia
25. Hypocal-cemia-induced pustular psoriasis of von Zumbusch
26. Effect of calcipotriol on psoriasis: a double-blind, placebo-controlled study of calcipotriol (MC 903) and calcium metabolism
27. 3
28. 3 of cultured psoriatic epidermal kerati-nocytes isolated from involved and uninvolved skin
29. 3
30. 3 treatment for psoriasis
31. 3 (calcitriol) in the treatment of psoriasis vulgaris: an open study
32. 3 in psoriasis
33. A double-blind placebo-controlled trial of topical 1,25-dihydroxycalciferol in psoriasis
34. 3 is a novel, safe, effective therapy for the treatment of psoriasis: a three year experience and histologic analysis [Abstract]
35. 3 ointment
36. Calcitriol cream in the treatment of psoriasis: efficacy and safety considerations
37. Synthesis of MC 903, a biologically active vitamin D metaboliteanalogue
38. Effect of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo
39. 3 analogue, stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes
40. 3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin-1 in vitro
41. 3 on alkaline phosphatase activity osterocalcin and DN A synthesis by human osteoblastic cells in culture
42. 3
43. 3 analogue (MC 903) in a double-blind study
44. Efficacy of topical treatment in psoriasis with MC 903, a new vitamin D analogue
45. Treatment of psoriasis by the topical application of the novel cholecaliferol analogue calcipotriol (MC 903)
46. Double-blind, right-left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
47. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris
48. Calcipotriol and hypercalcemia
49. 3 analogue
50. Long-term efficacy and tolerability of topical calcipotriol in psoriasis
51. Combination of topical calcipotriol (MC 903) and UVB radiation for psoriasis vulgaris
52. 3 on the growth of human keratinocytes
53. 3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity
54. 3 analogue, 1,24-dihydroxycholecalciferol
55. 3 analog, 1 alpha, 24-dihydroxycholecaliferol
56. 3 analogue MC 903 [Abstract]
57. 3 analogue MC 903 and betamethasone
58. Keratin gene expression during the resolution of psoriatic plaques: effect of dithranol, PUVA, etretinate and hydroxyurea regimens
59. 3 analogue calcipotriol
60. 3 derivative MC 903 in psoriasis: influence on cellular infiltrate, Langerhans cells and keratinocyte markers [Abstract]
61. 3 analogues: a novel class of potent regulators of cell growth and immune responses